Please login to the form below

Not currently logged in
Email:
Password:

Agios appoints Celgene’s Jackie Fouse

She joins the pharma group’s board of directors

Jackie FouseCancer and rare genetic disease focused group Agios Pharmaceuticals has appointed Jackie Fouse to its board of directors as the company prepares to launch its first precision medicine.

She said: “The execution across Agios’ research and clinical development programmes is remarkable, and I'm pleased to be joining the board during this exciting time.

“I look forward to working with the Agios team.”

Fouse’s career saw her join Celgene in 2010 as its chief financial officer and she most recently served as its president and chief operating officer until earlier this year.

Prior to her tenure at Celgene, Fouse worked for Alcon Laboratories, an ophthalmic pharmaceutical and medical device company.

David Schenkein, chief executive officer at Agios, said: “Through her tenure at Celgene we had the privilege of working with Jackie and seeing first hand the value she brings to a growing biotechnology company, so we are thrilled to welcome her to the Agios board of directors.”

14th December 2017

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics